Sei Investments CO Replimune Group, Inc. Transaction History

Sei Investments CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$15.65 - $24.1 $71,129 - $109,534	4,545 Added 35.31%	17,417 $404,000
Q1 2023 May 12, 2023	SELL	$17.48 - $29.09 $157,687 - $262,420	-9,021 Reduced 41.2%	12,872 $227,000
Q4 2022 Feb 10, 2023	BUY	$17.09 - $27.91 $374,151 - $611,033	21,893 New	21,893 $595,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $693M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.